��������

Combining extensive strategic leadership, scientific knowledge, and regulatory expertise, Dr. Kevin Barber supports Rho’s clientele in the development and execution of integrated regulatory strategies and clinical development plans for drugs, biologics, and medical devices.

With close to 25 years of experience in regulatory affairs and product development, Dr. Barber is a regulatory expert across all phases from preclinical through product launch and post-approval life cycle management. His significant experience moderating regulatory authority meetings and preparing and filing regulatory submissions includes more than 45 US INDs and more than 40 global marketing applications.

Throughout his career, Dr. Barber has participated in development programs for the treatment of infectious diseases across a range of products including new chemical entities, IVIG products, peptides, botanicals, and reformulations of existing chemical entities. His contributions for various antiviral, antifungal, and antibacterial indications have included the development of integrated regulatory strategies and clinical programs, facilitating regulatory agency interactions, and leading the preparation and submission of 8 INDs and 3 marketing applications.